6-15615268-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 1P and 12B. PP3BP6_Very_StrongBS1
The NM_032122.5(DTNBP1):c.487A>C(p.Arg163Arg) variant causes a splice region, synonymous change. The variant allele was found at a frequency of 0.000245 in 1,614,172 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00064 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00020 ( 0 hom. )
Consequence
DTNBP1
NM_032122.5 splice_region, synonymous
NM_032122.5 splice_region, synonymous
Scores
2
Splicing: ADA: 0.9822
2
Clinical Significance
Conservation
PhyloP100: 4.24
Publications
1 publications found
Genes affected
DTNBP1 (HGNC:17328): (dystrobrevin binding protein 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. A similar protein in mouse is a component of a protein complex termed biogenesis of lysosome-related organelles complex 1 (BLOC-1), and binds to alpha- and beta-dystrobrevins, which are components of the dystrophin-associated protein complex (DPC). Mutations in this gene are associated with Hermansky-Pudlak syndrome type 7. This gene may also be associated with schizophrenia. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
DTNBP1 Gene-Disease associations (from GenCC):
- Hermansky-Pudlak syndrome 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
BP6
Variant 6-15615268-T-G is Benign according to our data. Variant chr6-15615268-T-G is described in ClinVar as Likely_benign. ClinVar VariationId is 262011.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000643 (98/152328) while in subpopulation AFR AF = 0.00166 (69/41584). AF 95% confidence interval is 0.00134. There are 1 homozygotes in GnomAd4. There are 40 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DTNBP1 | NM_032122.5 | c.487A>C | p.Arg163Arg | splice_region_variant, synonymous_variant | Exon 6 of 10 | ENST00000344537.10 | NP_115498.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DTNBP1 | ENST00000344537.10 | c.487A>C | p.Arg163Arg | splice_region_variant, synonymous_variant | Exon 6 of 10 | 1 | NM_032122.5 | ENSP00000341680.6 |
Frequencies
GnomAD3 genomes AF: 0.000624 AC: 95AN: 152210Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
95
AN:
152210
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000406 AC: 102AN: 251432 AF XY: 0.000361 show subpopulations
GnomAD2 exomes
AF:
AC:
102
AN:
251432
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000203 AC: 297AN: 1461844Hom.: 0 Cov.: 31 AF XY: 0.000194 AC XY: 141AN XY: 727220 show subpopulations
GnomAD4 exome
AF:
AC:
297
AN:
1461844
Hom.:
Cov.:
31
AF XY:
AC XY:
141
AN XY:
727220
show subpopulations
African (AFR)
AF:
AC:
61
AN:
33480
American (AMR)
AF:
AC:
12
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
153
AN:
26132
East Asian (EAS)
AF:
AC:
0
AN:
39686
South Asian (SAS)
AF:
AC:
1
AN:
86256
European-Finnish (FIN)
AF:
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
32
AN:
1111992
Other (OTH)
AF:
AC:
38
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000643 AC: 98AN: 152328Hom.: 1 Cov.: 32 AF XY: 0.000537 AC XY: 40AN XY: 74494 show subpopulations
GnomAD4 genome
AF:
AC:
98
AN:
152328
Hom.:
Cov.:
32
AF XY:
AC XY:
40
AN XY:
74494
show subpopulations
African (AFR)
AF:
AC:
69
AN:
41584
American (AMR)
AF:
AC:
4
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
23
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1
AN:
68028
Other (OTH)
AF:
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Jan 16, 2020
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Dec 20, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.